A #WCPG2026 highlight! 🧬🌎
@PetersonRoseann presenting the LAGC-MDD work on depression genetics in Latin American populations.
Great to see this collaborative work and the LAGC-MDD Working Group represented in Glasgow!
A great week for POP-GEM and collaborators at #WCPG2026! 🧬
From depression and postnatal depression to PTSD, substance use, and cross-ancestry genomics—great to see the team sharing this work in Glasgow.
Thanks to everyone who stopped by!
#PsycheMERGE at #WCPG2026! 📸🧬
Madhurbain Singh, PhD, presented Poster W66 on our trans-ancestry and sex-stratified GWAS meta-analysis of depression diagnosis, pictured here with @PetersonRoseann.
Great to see the team representing PsycheMERGE in Glasgow!
A #WCPG2026 highlight! 📸🧬
@pbb2 presenting Poster W29 on the multivariate genetics of PTSD and problematic substance use.
Great to see Peter sharing this work with the psychiatric genetics community in Glasgow!
A few days later at #WCPG2026! 📸🧬
Jolien Rietkerk, PhD, presenting Poster W62 on postnatal depression and reproductive-related traits using CONVERGE and All of Us.
Great to see the work presented in Glasgow!
@timbigdeli, PhD, will present at #WCPG2026! 🧬
Genetic Diversity Refines the Architecture of Bipolar Disorder Risk across Human Populations
📅 Sat, Oct 3
⏰ 1:30–1:45 PM
📍 Lomond Auditorium
Dr. Bigdeli will also co-chair the Mood Disorders session.
🧬 POP-GEM is heading to #WCPG2026!
Our team and collaborators will be presenting research spanning depression, bipolar disorder, postnatal depression, PTSD, genetic diversity, and cross-ancestry genomics.
Follow this thread for where to find us at WCPG! 🧵👇
@PetersonRoseann, PhD, will present at #WCPG2026! 🧬
T67 | Genome-Wide Association Meta-Analysis of Depression in Latin American Populations from the LAGC-MDD Working Group
📅 Thu, Oct 1
⏰ 5–6:30 PM
📍 Hall 2
#LAGC#PsychiatricGenetics
Tan-Hoang Nguyen, PhD, will present at #WCPG2026! 🧬
W123 | GWAS-Informed Machine Learning Prediction of PTSD in the UK Biobank to Enhance Genetic Discovery
📅 Wed, Sept 30
⏰ 4:30–6 PM
📍 Hall 2
#PTSD#GWAS#MachineLearning
Jolien Rietkerk, PhD, will present at #WCPG2026! 🧬
W62 | Shared & Distinct Polygenic Profiles of Postnatal Depression and Reproductive-Related Traits in CONVERGE & All of Us
📅 Wed, Sept 30
⏰ 4:30–6 PM
📍 Hall 2
#PostnatalDepression#Genetics
Peter Barr, PhD, will present at #WCPG2026! 🧬
W29 | Multivariate Genome-Wide Association Study of PTSD and Problematic Substance Use
📅 Wed, Sept 30
⏰ 4:30–6 PM
📍 Hall 2
Stop by Poster W29 during Poster Session I!
#GWAS#PTSD#SubstanceUse
Madhurbain Singh, PhD, will present at #WCPG2026! 🧬
W66 | Trans-Ancestry & Sex-Stratified GWAS Meta-Analysis of MDD Diagnosis in 500,000 Cases & 2 Million Controls
📅 Wed, Sept 30
⏰ 4:30–6 PM
📍 Hall 2
#PsycheMERGE#PsychiatricGenetics
🧵 New publication from the PGC Anxiety Working Group. Our GWAS meta-analysis of anxiety disorders is now published in @NatureGenet! 🔗: https://t.co/fb3yGDEURn
New publication in @Nature. MVP EHR linked genomics enables ancestrally diverse analyses, uncovering ancestry independent signals, 100 plus new schizophrenia loci, and convergent neurobiology with global relevance. https://t.co/YXVqV80oOt
@timbigdeli@CChatzinakos@panos_roussos
New open-access Translational Psychiatry paper: multi-omic integration + drug repurposing to identify FDA-approved treatments for opioid use disorder. Led by POP-GEM’s @BToddWebb. Approach generalizable across complex traits & disorders.
https://t.co/tNEaSrM9Lw
#OUD
(1/2) Congrats to @TeddyWroblewski and team on their new JAMA Network Open paper using @AllofUsResearch data! The study reveals racial disparities in post-TBI neuropsychiatric outcomes and highlights the impact of structural factors on recovery.
@timbigdeli@NeuroChirGlobal
(1/6) We’re excited to present “Advancing the Understanding of Depression Genetics Through Research on Latin American Genomes” at #WCPG2025! 🌎✨
📅 Mon Oct 20 | 9:45–11:15 AM
📍 Blue River 3 – Convention Center (1st Floor), Cancún
Led by Drs. @PetersonRoseann, @NSCorralFrias🧵..
(5/6) Dr. Diana Núñez-Ríos will present analyses of CNVs in Colombian, Mexican, and Puerto Rican cohorts (947 cases, 310 controls), revealing complex admixture patterns and genetic variants linked to MDD. #WCPG2025#MDD